GenMark raises $75M in upsized follow-on

Molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen and Raymond James. The price is a 9% discount to GenMark’s close of $12.85 on Monday, before the company proposed after market hours to raise $65 million. GenMark shed $1.03 to $11.82 on Tuesday, then gained $0.38 to $12.20 on Friday...